https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.753240/full
Frontiers | A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via...
It is a viable strategy to inhibit osteoclast differetiation for the treatment of osteolytic diseases such as osteoporosis, rheumatoid arthritis and tumor bo...
frontierspreventsformationvia